The value of quantitative patient preferences in regulatory benefit-risk assessment

    Thumbnail
    Download
    Citations
    Altmetric
    Author
    oude Egbrink, M; IJzerman, M
    Date
    2014-04-01
    Source Title
    Journal of Market Access & Health Policy
    Publisher
    Co-Action Publishing
    University of Melbourne Author/s
    IJzerman, Maarten
    Affiliation
    Melbourne School of Population and Global Health
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    oude Egbrink, M. & IJzerman, M. (2014). The value of quantitative patient preferences in regulatory benefit-risk assessment. Journal of Market Access & Health Policy, 2 (1), pp.22761-22761. https://doi.org/10.3402/jmahp.v2.22761.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/259970
    DOI
    10.3402/jmahp.v2.22761
    Open Access at PMC
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865769
    Abstract
    Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of the solution on how to best involve patients in regulatory decision making. Progress is recently made on these issues.

    Export Reference in RIS Format     

    Collections